drugset / Trial / NCT06361433
Intracerebral Transplantation of Autologous MSC Combined With Scaffold Product for Chronic Intracerebral Hemorrhage
Phase 1/2
Unknown
8 enrolled
Hokkaido University Hospital
Japan Agency for Medical Research and Development · collab
NaSingle-groupOpen-labelTreatment
Summary
The goal of this clinical trial is to test intracerebral transplantation of stem cell product in patient with chronic intracerebral hemorrhage. The main questions aims to answer are: * The safety of the product * The efficacy of the product
Timeline
- Start
- 2023-12-01
- Primary completion
- 2026-02
- Completion
- 2026-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HUFF-01 | Cell therapy | 50000 unknown | Other |